BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1386132)

  • 1. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
    Monshizadegan H; Hedberg A; Webb ML
    Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
    Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
    J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
    Parent CA; Lagarde M; Venton DL; Le Breton GC
    J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of thromboxane A2/prostaglandin H2 receptors in porcine coronary artery--the inhibitory effect of a novel dibenzoxepin derivative, KW-3635.
    Miki I; Ishii A
    Thromb Haemost; 1992 May; 67(5):582-4. PubMed ID: 1387741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane A2/prostaglandin H2 receptor antagonists.
    Le Breton GC; Lim CT; Vaidya CM; Venton DL
    Methods Enzymol; 1990; 187():406-14. PubMed ID: 2146463
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
    Miki I; Nonaka H; Ishii A
    Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145.
    Hanasaki K; Nagasaki T; Arita H
    Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
    Theis JG; Dellweg H; Perzborn E; Gross R
    Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I; Kase H; Ishii A
    Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for functional thromboxane A2-prostaglandin H2 receptors in human placenta.
    Hedberg A; Mento PF; Liu EC; Hollander AM; Wilkes BM
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E256-63. PubMed ID: 2521985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor binding properties of the new and specific thromboxane receptor antagonist Bay U 3405.
    Darius H; Michael-Hepp J; Meyer J
    Agents Actions Suppl; 1992; 37():157-61. PubMed ID: 1385923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cells.
    Hanasaki K; Nakano K; Kasai H; Arita H
    Biochem Pharmacol; 1989 Sep; 38(18):2967-76. PubMed ID: 2528958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vascular and platelet thromboxane A2/prostaglandin H2 receptors in the pig.
    Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
    Eur J Pharmacol; 1989 Feb; 160(3):313-21. PubMed ID: 2523812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
    Webb ML; Liu EC; Monshizadegan H; Hedberg A; Misra RN; Goldenberg H; Harris DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1387-94. PubMed ID: 8450473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
    Hanasaki K; Arita H
    Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548).
    Kattelman EJ; Venton DL; Le Breton GC
    Thromb Res; 1986 Feb; 41(4):471-81. PubMed ID: 3008368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.